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ABSTRACT 
Mechanotransduction plays a key role in vascular development, physiology and 
disease states. Piezo1 is a mechanosensitive non-selective cationic channel present 
in endothelial and vascular smooth muscle cells. It is activated by shear stress 
associated with increases in local blood flow, as well as by cell membrane stretch 
upon elevation of blood pressure. Here we briefly review the pharmacological 
modulators of Piezo and discuss the present state of knowledge on the role of 
Piezo1 in vascular mechanobiology and associated clinical disorders, such as 
atherosclerosis and hypertension. Ultimately, we believe that this recent research 
will help identify novel therapeutic strategies for the treatment of vascular 
diseases.  
 
Blood flow generates a frictional force acting on the endothelium (shear stress, 
parallel to the vessel wall), as well as wall distension (stretch; a force perpendicular 
to the vessel wall) in response to changes in transmural pressure [1-4]. Shear stress 
can arise due to either laminar (smooth flow with fluid layers sliding in parallel) or 
turbulent (rough) flow of blood through the vasculature. These mechanical forces 
have a significant impact on vascular development, physiology and are implicated in 
various disease states, including atherosclerosis and hypertension [1-4]. Multiple 
mechanosensors (see Glossary) detect these mechanical forces within vascular cells, 
including elements of the extracellular matrix (ECM), adhesion molecules, the 
endothelium junctional complex, cytoskeletal components, G protein-coupled 
receptors [5], various ion channels [6-8] and a variety of signaling molecules, such as 
small GTPases and their effectors [9, 10].  
Upon mechanical stimulation by fluid flow or membrane stretch, opening of 
mechanosensitive (MS) ion channels at the plasma membrane of cells is the earliest 
(within microseconds) cellular event [11-16]. These MS ion channels are characterized 
by different structures, ionic selectivity and gating properties [11-17]. Dimeric 
TREK/TRAAK K2P channels are K+ selective and their opening causes cell 
hyperpolarization in response to membrane stretch [18]. By contrast, trimeric 
Piezo1/2 cationic channels are non-selective and permeable to Na+, K+ and Ca2+ and 
their activation in response to pressure stimulation (low threshold) or shear stress 
induces cell depolarization and Ca2+  influx [14, 19-21]. In addition, dimeric 
OSCA/TMEM63 non-selective cationic channels open in the high-pressure range 
(high threshold) [6, 22]. Here, we mainly focus on Piezo1, its role in cardiovascular 
mechanotransduction and properties as an emerging pharmacological target. 
 
Structural and functional properties of Piezo1  
Piezo ion channels are activated by mechanical stimuli such as localized membrane 
stretch, whole cell poking or fluid flow (i.e. shear stress) [14, 23]. Moreover, 
intracellular traction forces generated from myosin II phosphorylation by myosin 
light chain kinase are sufficient to generate spatially-restricted Piezo1-mediated Ca2+ 
flickers, in the absence of applied exogenous force (bioRxiv 294611; doi: 
https://doi.org/10.1101/294611). Piezo1 is present in peripheral tissues (including 
endothelial and arterial smooth muscle cells; ECs and SMCs), while Piezo2 (47% 
identity with Piezo1) is highly expressed in mechanosensory neurons and 
responsible for light touch, proprioception, reflex regulation of breathing and 
baroreception (see below) (for review [14]). Notably, both Piezo1 and Piezo2 are co-
expressed in the nodose and petrosal sensory neurons innervating the wall of the 
aorta and the carotid sinus [24]. Piezo1/2 ion channels are characterized by a fast 
inactivation mechanism (i.e. the amplitude of Piezo currents decreases with time, 
while mechanical stimulation is maintained), with a time constant ( of about 10 and 
20 ms for Piezo2 and Piezo1 at -80 mV, respectively) [19]. Mechanosensitivity is 
observed upon reconstitution of purified Piezo1 channels into artificial bilayers, 
indicating that the channel is a pore-forming subunit [25], directly activated by an 
increase in membrane tension [26]. While it was recently shown that Piezo1 flattens 
in the plane of the membrane in response to increased membrane tension [27 (the 
consequent increase in the in-plane channel cross sectional area is anticipated to 
provide the main driving energy controlling channel gating), currently only a closed 
state (or at least an inactive intermediate state) of Piezo1 is described {Saotome, 2018 
#2810, 28, 29](Figure 1A-B). Thus, the structure of the open state remains to be 
verified experimentally.  
The amino terminal domain of Piezo1 is thought to form the mechanosensor (made 
of nine repeats forming the blades, each containing four transmembrane segments), 
while the C terminal domain constitutes the ionic pore lined by the last 
transmembrane segment (inner helix), the C-terminal extracellular domain (CED) 
and the intracellular C-terminal domain (CTD) [28-31](Figure 1A-B). Piezo1 is curved 
with the amino terminal domains resembling the three blades of a propeller and the 
ionic pore located at the central axis (Figure 1A-B). Notably, the insertion of Piezo1 
into artificial liposomes causes a curvature of the membrane, forming a dome shape 
[29]. Piezo1 is predicted to deform the membrane into a “curved footprint” [32]. Thus 
Piezo1 may affect responses to curvature-sensitive molecules (for instance other MS 
ion channels) located in its vicinity [32].   
Conformational changes in the N terminal domain caused by force may be 
transmitted to the central pore by decreasing the angle between an intracellular helix 
(“beam”) beyond the channel and the membrane plane [33](Figure 1B). The main 
determinant of Piezo1 fast inactivation is an hydrophobic gate in the inner pore helix 
[34]. An unstructured domain located adjacent to the beam may act as a cytosolic 
plug that is thought to limit ion permeation possibly by clogging the inner pore of 
Piezo1/2 [35]. Of note, Piezo2 shares a similar trimeric structure with Piezo1, but 
shows an additional constriction site at the external side of the channel [36]. Whether 
or not a similar external constriction site is present in Piezo1 is unknown at this stage 
[28-31]. Thus, it remains possible that the available structures of Piezo1 may 
correspond to an intermediate inactive state. In some cell types, including ECs, native 
Piezo1 currents show a slow inactivation [37, 38]. Thus, Piezo1 in ECs remains open 
longer while flow is maintained constant. 
 
Pharmacological Modulators of Piezo channels 
Over the years, a small number of pharmacological modulators of piezo channels 
were used in various studies. We briefly lay put some of them below. 
GsMTx4: GsMTx4 is a peptide toxin from Grammostola spatulata spider venom that 
blocks cationic stretch-activated channels [39]. It is a positively charged amphipathic 
molecule that can insert into lipid bilayers and inhibit various cationic MS channels, 
including Piezo1, TREK-1 and the bacterial channel MscL [40-42] (Figure 1B-C). 
Piezo1 currents are reversibly inhibited by GsMTx4 with a Kd of ~155 nM [43]. Both 
enantiomeric forms of GsMTx4 inhibit Piezo1 [42]. Thus, GsMTx4 presumably acts 
by modulating local membrane tension near the MS channels and behaves as a 
gating modifier [39] (Figure 1B-C). 
Yoda1 and Dooku1: The pharmacology of Piezo1 has further emerged with the 
identification of a small molecule activator called Yoda1 (Figure 1B, D) (EC50: 17.1 
and 26.6 µM for mouse and human Piezo1, respectively)[44]. It is important to note 
that Yoda1 sensitizes the channel to mechanical stimulation, but is not able to 
activate the channel by itself without applied force (leftward shift in the pressure-
effect curve) [44]. A minimal region in Piezo1 [1961-2063] has been identified that is 
responsible for the activation by Yoda1 [45] (Figure 1A-B, magenta). Yoda1 enhances 
Piezo1 activation by pressure, but remarkably has no effect on the Piezo2 isoform [44, 
45]. The effect of Yoda1 is highly dependent on the dichloro substituents and on the 
oxidation state of the thioether linker [44, 46](Figure 1D-E). A Yoda1 analogue called 
Dooku1 reversibly antagonizes Yoda1 activation of Piezo1, but lacks a stimulatory 
effect [46](Figure 1D and Figure 2). One nitrogen shared by the pyrazine (Yoda1) and 
pyrrole (Dooku1) group also appears as an important feature for activity (Arrows in 
Figure 1D) [46]. These data suggest a pharmacophore that involves two mutually 
perpendicular planes, of which one plane is outlined by the dichlorophenyl ring and 
the other one is formed by the thiadiazole and pyrazine parallel rings (pyrrole group 
in the case of Dooku1) (Figure 1E).  
Jedi1 and Jedi2: In addition, two low affinity water soluble chemical activators, Jedi1 
and Jedi2 activate Piezo1 from the extracellular side (EC50: 200 and 158 µM for mouse 
Piezo1, respectively)[33] (Figure 1B, 1F). Extracellular loops 15-16 [657-677] and 19-20 
[870-921] within the blades are critically required for Piezo1 activation by Jedi1 and 2 
(Figure 1A-B, yellow).  
Gadolinium and ruthenium red: Further, gadolinium and ruthenium red (polycations) 
have also been used as non-specific blockers of native stretch-activated ion channels, 
as well as exogenous Piezo1 expressed in transfected cells [25, 47].  
 
Piezo1 is critically required for early vascular development 
Piezo1 is a key endothelial mechanosensor required for early vascular development 
[20, 21](Figure 3A-B, Key Figure). Between embryonic days E9 and 10.5, Piezo1 is 
expressed in the developing cardiovascular system, notably in the endothelium and 
endocardium [20, 21]. In the adult mouse, such expression persists in ECs, as well as 
in SMCs of resistance arteries)[48]. Piezo1 is also present in human umbilical vein 
and fetoplacental ECs [21, 46, 49].  
Constitutive genetic invalidation of Piezo1 is embryonically lethal [20, 21]. Piezo1-
deficient embryos die at mid-gestation, despite normal initial vasculogenesis until 
E9.5, indicating that angiogenesis per se is not impaired. In Piezo1 knock-out mice, 
the yolk sac, as well as the embryonal vasculature is disorganized, lacking major 
blood vessels [20, 21]. Embryos lacking Piezo1 exhibit major pericardial effusion, 
reflecting a defective circulation and die before E14.5 [20, 21]. A similar phenotype in 
mice with endothelium-specific deletion of Piezo1 (with embryonic or early post-
natal lethality) indicates that the defect in vascular architecture is caused by a lack of 
Piezo1 in ECs [21, 50].  
 
Piezo1 is an endothelial flow-activated non-selective cationic channel permeable to Ca2+ 
Patch-clamp recordings have demonstrated the evidence of both pressure- and flow-
activation of endothelial Piezo1, with a single channel conductance of about 25-30 
pico Siemens (pS) [20, 21]. Stimulation of Piezo1 in ECs by either pressure or flow 
only exhibits a slow current inactivation (i.e. channels remain open longer in 
response to mechanical stress) and causes a steady increase in intracellular Ca2+ 
concentration [21]. Remarkably, transfection of Piezo1 in HEK 293 cells confers 
sensitivity to shear stress [21]. The opening of endothelial Piezo1-channels by shear 
stress activates downstream Ca2+-dependent calpains (proteolytic enzymes) which in 
turn are responsible for focal adhesion turnover, proteolytic cleavage of actin 
cytoskeletal elements and alignment of ECs to blood flow [20, 21](Figure 3A, Key 
Figure). In line with these findings, it has been shown that genetic deletion of Piezo1 
or its inhibition with GsMTx4 suppresses shear stress-induced Ca2+-influx in ECs and 
impairs alignment of ECs to flow [20, 21]. Denser actin structures are detected in 
Piezo1-depleted ECs and the channels accumulate at the leading apical lamellipodia, 
a site where focal adhesions turnover is enhanced upon alignment to flow [21]. In 
addition, opening of Piezo1 and the resulting Ca2+ influx in response to shear stress 
or to the pro-angiogenic factor sphingosine 1-phosphate (S1P), presumably in the 
absence of mechanical stimulation, causes the activation of the matrix 
metalloproteinase-2 (MMP-2) and membrane type 1 matrix metalloproteinase (MT1-
MMP) in ECs causing endothelial sprouting (Figure 3B, Key Figure) [51]. Thus, 
Piezo1 is critically required during early development for alignment and migration 
of ECs to blood flow, capillary network formation, determining number of vessel 
branch points and tube- length [20, 21, 51](Figure 2A-B, Key Figure). Likewise, in 
adult animals, conditional Piezo1 deletion in the endothelium impairs angiogenesis 
under conditions of wound injury or hindlimb ischemia [51].  
 
Piezo1 is required for morphogenesis of valves 
Lymphatic valves 
Lymphatic vessels transport extravasated fluid back to the venous circulation,  
antigens and antigen-presenting cells to the lymph nodes and play a key role in the 
absorption of dietary fats [52]. The active propulsion of the lymph to the venous 
circulation occurs by synchronizing peristaltic waves and the opening/closing of   
intraluminal valves in the lymphatics [53]. The latter valves, originate from 
lymphatic ECs which develop into elongated valve leaflets following reorientation, 
active migration and matrix organization [54].  
PIEZO1 recessive loss-of-function mutations cause congenial lymphatic dysplasia 
[55, 56], an inherited altered development of the lymphatic system that causes 
leakage of lymph fluid into the limbs. Moreover, in the mouse, specific invalidation 
of Piezo1 in ECs caused impaired lymphatic valve formation, leading to pleural 
effusion [50, 57]. Moreover, conditional Piezo1 invalidation in adult lymphatics 
caused substantial lymphatic valve degeneration [57]. Expression of the transcription 
factors forkhead box C2 (FoxC2) and nuclear factor of activated T cells 1  (NFATc1, 
implicated in the early induction of lymphatic valves), as well as the number of valve 
forming region were not altered upon Piezo1 deletion in ECs [50]. However, Piezo1 
knockdown in cultured lymphatic ECs prevented the up-regulation of the lymphatic 
valve signature genes induced by oscillating shear stress [57]. Conversely, activation 
of Piezo1 by Yoda1 accelerated lymphatic valve formation in animals and also 
triggered upregulation of lymphatic valve genes in cultured lymphatic ECs in the 
absence of mechanical stimulation [57]. In the same line, activation of Piezo1 with 
Yoda1 induced remodeling of actomyosin and cell-cell adhesion sites in cultured 
lymphatic ECs [50]. In brief, collective migration, actin polymerization and 
remodeling of cell-cell junctions were impaired upon deletion of Piezo1 in ECs [50]. 
These findings clearly indicate that shear stress activation of Piezo1 is responsible for 
lymphatic valve morphogenesis [50, 57].  
Arterial and venous valves 
Three rare PIEZO1 heterozygous variants, with minor allele frequencies <1%, have 
been found to be associated with bicuspid aortic valves in humans (bioRxiv 368365; 
doi: https://doi.org/10.1101/368365). Those variants (Y2022H, K2502R and S217L) 
produce inactive PIEZO1 channels and behave as dominant negative mutants when 
co-expressed with wild-type channels. Moreover, piezo1 has also been shown to be 
involved in the formation of  arterial valves in  zebrafish (bioRxiv 368365; doi: 
https://doi.org/10.1101/368365 and bioRxiv 528588; doi:https://doi.org/10.1101/528588). 
In addition, Piezo1 is required for mouse venous valve formation [50]. In the same 
line, a single nucleotide  polymorphism (SNP rs2911463) in PIEZO1 is associated 
with varicose veins of the lower extremities [58], but whether or not this variant 
affects channel function per se is unknown. 
 
Ultimately, taken in conjunction, these findings suggest a key role for Piezo1 in the 
development of arterial, lymphatic and venous valves. 
 
Endothelial Piezo1 mediates flow-dependent vasodilatation and atheroprotection 
Vasodilator factors such as nitric oxide (NO), released from the endothelium in 
response to increased blood flow contribute to the regulation of arterial blood 
pressure [59, 60]. Shear stress activation of Piezo1 in mesenteric arteries  releases ATP 
from ECs, partly through pannexin channels, which in turn stimulates P2Y2 
purinergic receptors in an autocrine manner [61] (Figure 3C, Key Figure).  The 
downstream Gq/G11-mediated activation of the MS complex PECAM-1, VE-cadherin 
and VEGFR2 enhances phosphorylation of endothelial nitric oxide synthase (eNOS) 
at Ser 1176 via PI3K/AKT, resulting in NO production [61](Figure 3C, Key Figure). In 
synergy, the increased flow induces, in a yet to define way, Piezo1-dependent release 
of adrenomedullin from the endothelium causing phosphorylation of eNOS at Ser 
632 by PKA downstream of Gs-coupled CALCRL/RAMP2 receptors, thus further 
enhancing NO levels [62](Figure 3C, Key Figure). Increased NO levels in turn 
mediates vasodilatation (Figure 2 and Figure 3C, Key Figure). 
Endothelial invalidation of Piezo1 at the adult stage (conditional knock-out) causes a 
blunted in vivo eNOS phosphorylation and decreased NO release possibly associated 
with an increased systolic blood pressure [61].  In mesenteric arteries or aortic rings 
of adult mice, conditional knock-out of Piezo1 in the endothelium prevents flow- or 
Yoda1-induced vasodilatation, although endothelium-dependent relaxations to 
acetylcholine, as well as endothelium-dependent contractions to the α1-adrenergic 
agonist, phenylephrine (PE) or the thromboxane-prostanoid (TP) receptor activator 
U46619 are preserved [46, 61](Figure 2). Similar findings were obtained with 
endothelial deletion of P2Y2, Gq/G11 or pannexin 1/2 [61]. In addition, mice with 
endothelial specific invalidation of adrenomedullin, adrenomedullin receptors or 
Gs also exhibit decreased release of NO in response to shear stress, impaired flow-
dependent vasodilatation and are hypertensive [62]. Treatment with Yoda1 also 
causes relaxation of murine intrapulmonary arteries in a Piezo1- and NO-dependent 
manner [63]. However, endothelial invalidation of Piezo1 does not influence the 
development of pulmonary hypertension in response to chronic hypoxia [63]. In rats, 
Piezo1 has also been shown to mediate flow-dependent vasodilatation of uterine 
arteries during pregnancy [64]. Accordingly, Yoda1 produces relaxation of pre-
constricted uterine arteries [64]. Finally, inhibition of Piezo1 expression in the 
endothelium by miR-103a is involved in acute myocardial infarction by influencing 
endothelium function [65]. 
 
Taken in conjunction, these data suggest that Piezo1-activation by shear stress 
regulates NO release by the endothelium, thereby influencing local vascular tone 
and, in turn, arterial blood pressure [20, 21, 46, 49, 61] and exerting an 
atheroprotective role (Figure 3C, Key Figure).  
 
Activation of Piezo1 by turbulent flow promotes atherogenic endothelial 
inflammation 
As discussed above, Piezo1 opening induced by laminar flow exerts an 
atheroprotective effect resulting from eNOS activation and NO release [2, 59, 66-
68](Figure 3C, Key Figure). However, at the inner (but not at the outer) curvature of 
the aortic arch where ECs are subjected to turbulent flow, Piezo1 activation induces 
endothelial inflammation and atherosclerosis [2, 59, 66-68]. Indeed, it has been 
observed that upon conditional endothelial Piezo1-deletion, the accumulation of 
endothelial inflammatory cells is reduced [69]. Moreover, endothelial deletion of 
Piezo1 or Gq/G11 in mice lacking low density lipoprotein (LDL) receptors and fed a 
high fat diet attenuates endothelial inflammation, as well as neointima formation 
after partial carotid ligation, causing atherosclerosis [69]. Integrin 5 and FAK 
activations are enhanced by turbulent flow in a Piezo1-/Gq/G11-dependent manner, 
causing stimulation of the NF-kB pathway and expression of pro-atherogenic genes 
[69](Figure 3D, Key Figure).  
 
Collectively, these findings indicate that activation of Piezo1 by laminar flow is 
atheroprotective by eNOS stimulation [69](Figure 3C, Key Figure), while turbulent 
flow contributes to atherosclerosis through the NF-kB pathway (Figure 3D, Key 
Figure).  
Endothelial Piezo1 mediates exercise-induced mesenteric vasoconstriction 
Besides NO, additional relaxing factors, including prostacyclin, arachidonic acid 
metabolites, H2O2, CO2, H2S and peptides are released by the endothelium, causing 
the opening of various K+ channels in SMCs [70]. In addition, opening of the small 
and intermediate conductance Ca2+-activated K+ channels (SKCa2+ and IKCa2+, 
respectively) in the endothelium also causes hyperpolarization of electrically coupled 
SMCs through gap junctions (Figure 4A). In parallel, K+ efflux (predominantly 
through endothelial IKCa2+) also activates Kir channels of SMCs (increase in single 
channel conductance) and/or stimulates their Na+/K+ ATPase, also contributing to 
hyperpolarization and relaxation (Figure 4A). The resulting hyperpolarization at rest 
(i.e. without physical exercise), known as endothelium-dependent hyperpolarization 
(EDH) leads to relaxation (in this case of mesenteric arteries; Figure 4A). EDH-
dysfunction is involved in various disease states, including hypertension, and the 
various players acting in EDH are increasingly recognized as putative therapeutic 
targets [70].    
By contrast, physical exercise-induced high blood flow enhances Piezo1 opening and 
causes depolarization of mesenteric artery ECs, due to the influx of Na+ and Ca2+ 
(Figure 3E, Key Figure and Figure 4B). Depolarization is transmitted to the 
electrically coupled SMCs through gap junctions and triggers vasoconstriction 
mediated by the opening of nicardipine (dihydropyridine)-sensitive CaV1.2 channels 
(Figure 4B). EDH, that can be prevented by a mixture of the K+ channel blockers 
apamin and charybdotoxin, is amplified in the mesenteric arteries of mice lacking 
endothelial Piezo1 [38]. Indeed, it has been shown that when mice were active on 
running wheels at night, invalidation of Piezo1 in ECs significantly lowered the 
elevated blood pressure [38]. Mice lacking endothelial Piezo1 exhibited reductions in 
distance runs, percentages of active time and number of active bouts of exercise [38]. 
Thus, endothelial Piezo1 plays a role in increasing blood pressure upon exercise and 
its opening in the endothelium by the high blood flow exerts an anti-EDH effect 
[38](Figure 3E and Figure 4B). However, it is important to note that the contribution 
of endothelial Piezo1 to flow-induced depolarization/constriction appears to be 
specific for the mesenteric circulation, as the EDH-mediated response is not 
amplified by Piezo1 invalidation in either saphenous or carotid arteries [38].  
In summary, these findings demonstrate that endothelial Piezo1 activation by high 
blood flow associated with physical exercise contributes to the vasoconstriction of 
the mesenteric circulation (along with sympathetic activation), thereby optimizing 
physical performance [38](Figure 3E, Key Figure and Figure 4B).  
 
Piezo1 is involved in vascular hyperpermeability 
It has been shown that when lung microvessel-pressure is elevated by raising left 
atrial pressure or by aortic constriction, the resulting leakage of serum is abrogated 
by conditional endothelium specific invalidation of Piezo1 or its in vivo inhibition 
with GsMTx4 [71], thus indicating that pressure-induced opening of Piezo1 in ECs of 
lung microvessels mediates endothelial barrier disruption [71](Figure 3A, Key 
Figure). Pharmacological inhibition of calpain mimics the protective effect of Piezo1 
invalidation [71], suggesting that Piezo1-opening results in calpain activation with 
subsequent degradation of the adherens junction proteins and leads to 
disintegration of the endothelial barrier (Figure 3A, Key Figure). Pulmonary edema 
which commonly occurs at high altitude (in people affected by mountain sickness), 
as well as during heart failure and after head trauma, is caused by leakage of plasma 
into the lung parenchyma when the endothelial barrier of lung capillaries is 
disrupted due to elevated hydrostatic pressure [72]. These findings suggest that 
pharmacological inhibition of Piezo1 might therefore be beneficial in the context of 
lung edema. 
 
Piezo1 in arterial SMCs mediates hypertensive arterial remodeling 
Expression of Piezo1 is strong in SMCs of resistance arteries, but sparse in conduit 
arteries [48]. Accordingly, patch clamp recordings reveal large stretch-activated non-
selective (i.e. with a reversal potential close to 0 mV) cationic currents in myocytes 
that arise from resistance arteries, and little currents or not from conduit arteries [48]. 
Conditional deletion of Piezo1 in arterial  SMCs fully suppress the MS currents in 
resistance artery myocytes [48]. Although myogenic constrictions induced by an 
increase in intraluminal pressure (of either mesenteric or cerebral arteries) are 
independent of smooth muscle Piezo1, the channel is involved in the arterial 
remodeling of resistance arteries during chronic hypertension [48](Figure 3F, Key 
Figure). Thus, unlike in normotensive animals, the deletion of SMC Piezo1 decreases 
arterial diameter, as well as media thickness under hypertensive conditions, resulting 
in a lower cross-sectional area [48].  
Piezo1 opening causes an increase in cytosolic Ca2+-concentration which stimulates 
transglutaminase II (TGII) activity, an enzyme involved in the remodeling of the 
cytoskeleton, as well as of the ECM [48](Figure 3F, Key Figure).  Indeed, it has been 
observed that in vivo inhibition of TGII by cystamine reverses Piezo1-dependent 
remodeling [48]. These findings establish a functional connection between Piezo1 
opening in vascular SMCs and a clinically relevant arterial remodeling that 
contributes to systemic hypertension.  
 
Role of Piezo1/2 in the baroreceptor reflex 
Upon an increase in arterial blood pressure, baroreceptor nerve endings in the wall 
of the aortic arch and carotid sinus are stretched triggering an afferent signal to the 
brain that stimulates the vagal nerve to slow down heart rate and reduces 
sympathetic tone to the vascular periphery, thereby allowing a normalization of 
blood pressure [73]. Dysfunction of the baroreflex is associated with premature death 
in patients suffering from postmyocardial infarction {Stocker, 2019 #2924.  
Both Piezo1 and Piezo2 are expressed in the nodose-petrosal-jugular ganglion 
complex which includes the neuronal cell bodies of the baroreceptors {Zeng, 2018 
#2803}. Genetic invalidation of both Piezo1 and Piezo2 in the nodose and petrosal 
sensory ganglia of mice fully impairs the baroreflex induced by an increase in blood 
pressure following phenylephrine (PE)-infusion [24]. Aortic depressor nerve activity 
is suppressed and the blood pressure variability of these double knock-out mice is 
enhanced [24]. Consequently, these show labile hypertension and increased blood 
pressure variability, recapitulating the clinical phenotype of human patients with 
baroreflex failure. However, it is interesting to note that invalidation of either Piezo1 
or Piezo2 alone does not affect the baroreflex, compared to the controls [24]. 
Conversely, optogenetic activation of Piezo2-positive sensory afferents initiates the 
baroreflex [24]. These findings indicate that Piezo1 and Piezo2 work in concert on MS 
nerve endings of the baroreceptors, to modulate baroreceptor reflex.  
 
Conclusions and future perspectives 
 
The variety of the current research indicates that the Piezo1/2 cationic MS channels 
play a key role in multiple aspects of cardiovascular development and physiology 
and are involved in development of various disease states, including atherosclerosis 
and hypertension. Piezo1 is required for vasculogenesis during early development 
with a key function in the alignment of ECs to blood flow, sprouting and formation 
of endothelial tubes (Figure 3A-B, Key Figure) [20, 21]. Moreover, Piezo1 is involved 
in the formation of lymphatic, arterial and venous valves [50, 58]. Further, 
endothelial Piezo1 mediates flow-dependent vasodilatation of the mesenteric 
circulation by stimulating the release of NO [61], while vasoconstriction of the 
mesenteric circulation during physical exercise (Figure 3C and 3E, Key Figure) [38]. 
Notably, opening of Piezo1 by laminar blood flow is atheroprotective, while its 
activation by turbulent flow mediates endothelial inflammation [69](Figure 3C and E, 
Key Figure). Interestingly, stimulation of Piezo1 opening in lung capillaries by 
elevated hydrostatic pressure causes endothelial barrier disruption and edema 
(Figure 3A, Key Figure) [71]. Moreover, in SMCs of resistance arteries, Piezo1 
contributes to hypertensive arterial remodeling [48] (Figure 3F, Key Figure). Finally, 
both Piezo1 and Piezo2 are required for proper baroreceptor function as their double 
invalidation causes labile hypertension and blood pressure variability [24]. 
Thus, the clinical phenotypes associated with genetic mutations in both human 
PIEZO1/2 genes, as well as the experimental phenotypes of various invalidation 
mouse models demonstrate the key importance of this class of MS ion channels. 
Although, the functional role of Piezo1/2 in cardiovascular pathophysiology is now 
well established, their pharmacology remains limited to low affinity drugs (activators 
and blockers) with poor solubility and stability that preclude in vivo usage [33, 44, 
46](Figure 1). Thus, more work will be required to identify additional modulators.  
 
Various outstanding questions also need to be addressed for a better understanding 
of the function and for improving the pharmacology of Piezo1: 
- What is the 3-D structure of the Piezo1 open state? Recent structural (cryo electron 
microscopy of reconstituted Piezo1 in lipid vesicles) and functional (high speed 
atomic force microscopy) findings indicate that Piezo1 flattens upon activation and 
thereby affects local membrane curvature [27]. It is thus anticipated that Piezo1 
gating might affect the function of neighboring proteins that are sensitive to 
membrane curvature, including other types of MS channels and/or membrane 
receptors [27, 29, 32]. Thus, it will be important to explore the collective behavior of 
different types of MS ion channels. 
- Is Piezo1 activated by endogenous openers (i.e. “Yoda1-like” molecules) and/or 
inhibited by endogenous blockers (i.e. “GsMTx4-like” molecules)[43]? At this stage, 
only S1P was claimed to activate endothelial Piezo1, independently of force [51]. By 
contrast, the short chain saturated margaric fatty acid (conjugated to phospholipids), 
was shown to inhibit channel opening [74]. Moreover, cholesterol depletion was also 
reported to lower Piezo1 activation by membrane stretch (right shift of the pressure-
effect curve) (bioRxiv 604488; doi: https://doi.org/10.1101/604488). Thus, lipids appear 
to be important endogenous modulators of Piezo1 opening and more work is 
required for a better understating of their role in vascular mechanobiology. 
- Is the effect of shear stress on Piezo1 direct or does it involve an additional flow 
sensor? Does glycosylation of Piezo1 condition its flow activation? What is the role of 
the extracellular matrix in shear stress activation of Piezo1? Does Piezo1 interact 
with adhesion molecules and what is the impact on Piezo1 activation by force? 
Interestingly, recent findings indicate a partnership between Piezo1 and adhesion 
molecules mediating sub cellular tuning of force response (bioRxiv 602532; doi: 
https://doi.org/10.1101/602532). 
- Why does native Piezo1 lack or show slow inactivation in specific cell types, 
including EC,  mesenchymal stem cells and epithelial renal cells [21, 37, 75]? Whether 
or not Piezo1 variants possibly influencing inactivation are expressed in ECs is 
unknown at this stage. 
- Are varicose veins associated with a dysfunctional Piezo1?  
- Is Piezo1 expressed at the primary cilium of ECs and does it contribute to flow-
dependent dilatation? Previous findings indicated that the polycystins TRPP1/TRPP2 
at the primary cilium, facing the luminal side of ECs, mediate flow-dependent 
activation of the endothelium [76, 77]. Moreover, the TRPP1/TRPP2 ratio was shown 
to modulate the gating of cationic non-selective stretch-activated channels 
(presumably Piezo1) in arterial myocytes [75, 78]. Whether or not Piezo1 is targeted 
to the primary cilium of ECs and similarly modulated by polycystins is currently 
unknown. 
- What is the role of Piezo1 in pulmonary artery remodeling? A role for Piezo1 in 
arterial myocytes was shown in hypertension-dependent arterial remodeling of 
resistance arteries of the general circulation [48]. Whether or not a similar role is at 
play in the pulmonary circulation needs to be investigated. 
- Is Piezo1 a potential pharmacological target for the treatment of hypertension 
and/or atherosclerosis? Since Piezo1 is involved in hypertension-induced arterial 
remodeling, as well as atherosclerosis associated with turbulent flow, “blockers” 
might exert beneficial in these disease states. However, since Piezo1 is broadly 
expressed (including in red blood cells and immune cells [79-81], it is anticipated that 
inhibition of its function might cause important side effects. 
- What is the pharmacology of Piezo2? It will be useful to identify both activators and 
inhibitors of the Piezo2 isoform that, besides its role in the baroreceptors, also plays a 
key role in touch sensing, proprioception and lung inflation-induced apnoea [82-87]. 
The high resolution structure of Piezo2 was recently solved and opens up novel 
opportunities for drug design [36]. 
-Besides the low threshold Piezo1/2 channels, the high threshold non-selective 
cationic MS channels OSCA/TMEM63 have also been recently discovered [6, 22, 88-
90]. What are the physiological roles of the TMEM63 isoforms in the cardiovascular 
system? What is their pharmacology? 
-Although current research strongly suggests a role for Piezo1/2 in the baroreflex, 
there are still some concerns [73]. In particular, localization of Piezo1/2 within nerve 
terminal endings in the arterial wall is not yet demonstrated at the protein level 
(although optogenetic experiments suggest that it might well be the case [24]). Also, 
controls for nerve viability in the double Piezo1/2 knock-out mice are also required 
[24]. Moreover, the validity of blood pressure measurements was questioned, 
considering: i) low pulse pressure values (difference between systolic and diastolic 
blood pressure); ii) important delays between the increase in blood pressure induced 
by PE-infusion and the increase in aortic depressor nerve activity in the report by 
[24]; iii) requirement for very large increases in blood pressure to evoke the 
baroreflex; iv) absence of baseline blood pressure or heart rate values; v) lack of 
findings with decreased blood pressure [24, 73]. Thus, further experiments will be 
required to confirm a definitive role for Piezo1/2 as the baroreceptor transduction 
channels [24, 73]. Of note, other candidate ion channels, including the epithelial 
sodium channel or acid-sensing ion channels (ASIC), as well as TRPC5 are involved 
in the baroreflex [91-93] and have been proposed to act as MS channels in vascular 
cells. Whether or not those channels might work in concert (either upstream, 
downstream or in parallel) with Piezo1/2 is unclear at this stage and will need to be 
addressed in future studies.  
 
In conclusion, the recent findings about structure-function relationships, genetic, 
physiological and pharmacological properties of Piezo1/2 advance in a major way 
our understanding of vascular mechanobiology. We hope that these will contribute 
in identifying novel therapeutic strategies for the treatment of major vascular disease 
states, including atherosclerosis and hypertension.  
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FIGURE LEGENDS 
 
Figure 1: Structure and pharmacological modulators of Piezo1  
Piezo1 (PDB 6B3R; ribbon representation) is made of a trimer of subunits with the 
ionic pore located at the center of the triskelion. Shown here are the top (A) and the 
side (B) view of the 3-D atomic structure of Piezo1 (presumably in closed or inactive 
state) where each monomer is colored in blue, light gray and dark gray respectively. 
The dashed red lines illustrate the curvature of the molecule (i.e. membrane plane). B 
also shows the interactions of different pharmacological modulators of piezo1: 
GsMTx4, Yoda1, and  Jedi1. The molecular surface of these small molecules is colored 
by the color of its closest atom. The critical region in Piezo1 required for Yoda1 
activation [1961-2063] and the N-terminal extracellular loops ([657-677] and [870-
921]) required for Jedi1/2 activation are shown in magenta and yellow respectively.  
The structures and pharmacological molecules are at scale. (C) Structure of GsMTx4 
(hydrophobic residues in green and positively charged residues in blue). The 
primary sequence of the GsMTx4 sequence is: 
  
(D) Yoda1 and its analogue, Dooku1 are shown.  Dooku1 prevents Piezo1 activation 
by Yoda1 in the micromolar range. (E) Pharmacophore features of Yoda1 family of 
compounds resulting from available structure-activity relationships analyses, are 
illustrated. Orange circles and lines indicate pharmacophore points and molecular 
geometry.  The pharmacophore involves two mutually perpendicular planes, of 
which one plane is outlined by the dichlorophenyl ring and the other one is formed 
by the thiadiazole and pyrazine parallel rings (pyrrole group in the case of Dooku1). 
(F) Jedi1 and Jedi2 are water soluble small molecule Piezo1 activators acting in the 
millimolar range within the blade domains of Piezo1 (in yellow panels A-B).  
 
Figure 2: Endothelial Piezo1 mediates vasorelaxation 
Thoracic aortas from Piezo1+/+ mice were contracted by the addition of PE (acting on 
SMCs) [46]. Vasorelaxation was induced by the addition of Yoda1, that activates 
Piezo1 in ECs [46]. Similar findings were observed with rat uterine arteries [64].  
Moreover, in pre-contracted mesenteric arteries from Piezo1+/+ mice, increased 
intraluminal flow or Yoda1 induced relaxation [61]. Yoda1-induced aorta relaxation 
was inhibited by Dooku1 (a Yoda1 analogue that does not activate Piezo1) [46]. 
Notably, removing the endothelium or conditional deletion of Piezo1 prevented 
relaxation by either Yoda1 or increased intraluminal fluid flow [46, 61].  
 
Figure 3 (Key Figure): Piezo1 in vascular mechanotransduction. (A) Activation of 
Piezo1 by shear stress (laminar flow: blue arrow) during early development is 
required for alignment of ECs to flow through a Ca2+-dependent activation of calpain 
and cleavage of focal adhesion molecules. Opening of Piezo1 by high hydrostatic 
pressure (P, red arrow) in lung capillaries causes disruption of endothelial adherens 
junctions by Ca2+-dependent activation of calpain, ultimately leasing to endothelial 
barrier disruption (associated with lung edema). (B) Activation of Piezo1 by laminar 
flow or sphingosine 1 phosphate (S1P) (presumably in the absence of mechanical 
stress) regulates the activation and membrane translocation of membrane type-1 
matrix metalloproteinase (MT1-MMP), inducing ECs sprout formation. (C) Laminar 
blood flow induces vasodilatation through Piezo1 activation and  release of NO 
(phosphorylation of eNOS S1176 and S632) and is atheroprotective. (D) Turbulent 
flow is atherogenic by a Piezo1-dependent stimulation of the NFkB pathway.  (E) 
Activation of endothelial Piezo1 by high blood flow upon physical exercise induces 
depolarization of mesenteric artery SMCs through gap junctions, activates CaV1.2 
causing calcium entry and induces vasoconstriction. (F) Opening of Piezo1 in SMCs 
of resistance arteries plays a role in arterial remodeling through stimulation of 
transglutaminase II. In C-D, atheroprotective and atherogenic processes are depicted 
in blue and red boxes respectively. 
 
Figure 4: Endothelial Piezo1 exerts an anti EDH effect. (A) At rest (low blood flow) 
Piezo1 opening within the endothelium of mesenteric arteries is limited and EDH is 
associated with relaxation. Increase in endothelial Ca2+ in response to acetylcholine 
stimulation of the muscarinic M3 receptor promotes the opening of both IKCa2+ and 
SKCa2+. The resulting hyperpolarization is transmitted to SMCs through gap 
junctions. Hyperpolarization causes relaxation by closing of CaV1.2 channels 
(membrane potential is below the voltage threshold of CaV1.2 activation). (B) Upon 
physical exercise causing high blood flow in the mesenteric circulation, opening of 
endothelial Piezo1 leads to cell depolarization due to the influx of Na+ and Ca2+. 
Depolarization is transmitted to electrically coupled SMCs through gap junctions 
(shown by yellow rectangles). Activation of CaV1.2 by cell depolarization causes a 
Ca2+ influx that triggers contraction of the myocytes. Piezo1 activation in the 
endothelium by high blood flow (i.e. shear stress) antagonizes EDH (endothelium-
dependent hyperpolarization). 
 
 
 
GLOSSARY 
Adherens junction: protein complex at cell-cell junctions. 
Angiogenic factor: a molecule that plays a role in blood vessel formation. 
Baroreceptor: mechanosensory neurons specialized in sensing changes in blood 
pressure. 
Cell depolarization: positive change in the membrane potential. 
Channel inactivation : closing of the channel despite a maintained stimulation 
(mechanical in the case of Piezo channels). 
Enantiomer: is one of two stereoisomers that are mirror images of each other non-
superposable. 
Focal adhesions: macromolecular complex containing integrins that establish a link 
between the cytoskeleton (inside the cell) and the extracellular matrix (ECM). 
Ionic selectivity: the type of ion flowing through a channel 
Lamellipodia: actin projection at the leading edge of a cell. 
Lymph node: are major sites of B and T lymphocytes and other white blood cells. 
Mechanosensor: a molecule specialized in sensing force. 
Neointima: scar tissue that forms on the wall of blood vessels following lesions or 
injury. 
Nitric oxide (NO): vasodilator gas produced by the endothelium in response to 
acetylcholine or bradykinin stimulation. 
Optogenetic: biological technique that uses light to control various biological 
processes. 
Pannexins: large transmembrane channels (similar to gap junction hemichannels) 
connecting the intracellular and extracellular space, allowing the passage of ions and 
small molecules between these compartments, including ATP. 
Patch-clamp: electrophysiological technique allowing for ion channel recordings. 
Peristaltic wave: smooth muscle cells contract in sequence to produce a wave 
allowing propulsion of lumen content. 
Pharmacophore: represents the spatial arrangement of features that is essential for a 
molecule to interact with a specific target (Piezo1 in the present case). 
Purinergic receptor: a membrane receptor activated by ATP. 
Resistance artery: small diameter artery controlling local blood flow. 
Shear stress: force vector component parallel to the wall of the artery. 
Single channel conductance: A measure of the size of the ionic pore. 
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